Abingdon Health Plc

ABDXFOTCHealthcare● Active

$0.17

+$0.00(+0.00%)

Market Cap$32218912

P/E Ratio—

52W High$0.209

52W Low$0.07

Avg Volume2K

Open$0.18

Beta0.18

Free Cash Flow Financials Revenue

Abingdon Health Plc (ABDXF) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

ABDXF · free cash flow · updated Jun 9, 2026

Core FCF metrics

ABDXF · FCF · TTM · margin & CAGR

Free cash flow was −$3.5M for FY2025 (fiscal year ending 2025-06-30), down 107.5% year-over-year The FCF margin was -41.9%.

FY2025 Free Cash Flow−$3.5M▼ -107.5% YoY

Trailing 12M (TTM)−$5.3Mtrailing 4 quarters sum

FCF Margin-41.9%−$3.5M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

ABDXF · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest−$3.2M(0M)−$3.5M▼ 107.5%-41.9%

FY2024−$1.7M(0M)−$1.7M▼ 301.2%-27.7%

FY2023$1.0M(0M)$845,000▲ +109.9%20.9%

FY2022−$7.7M(1M)−$8.5M▲ +57.8%-299.6%

FY2021−$12.9M(7M)−$20.1M▼ 4707.6%-173.2%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

ABDXF · P/FCF · FCF yield · FCF per share

Abingdon Health Plc (ABDXF) reported negative free cash flow of −$0.00B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-06-30

Cash flow statement summary

ABDXF · cash flow statement · operating / investing / financing

For FY2025, Abingdon Health Plc generated −$3.2M in operating cash flow and spent 0M in capital expenditures, yielding −$3.5M in free cash flow.

Operating Activities

−$3.2M

Cash from core business operations

2025-06-30

Investing Activities

−$1.4M

CapEx, acquisitions & investments

2025-06-30

Financing Activities

+$5.1M

Buybacks, dividends & debt

2025-06-30

FCF FormulaOperating CF (−$3.2M) − |CapEx| (0M) = FCF (−$3.5M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

ABDXF vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Abingdon Health PlcYOU

ABDXF

−$3.5M-107.5%-41.9%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Abingdon Health Plc (ABDXF) reported free cash flow of −$3.5M for FY2025 (fiscal year ending 2025-06-30), down 107.5% year-over-year. The FCF margin was -41.9%.

Based on available data, Abingdon Health Plc has maintained positive free cash flow for at least 2 fiscal year(s). FCF peaked at $845,000 in FY2023.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

ABDXF free cash flow · 8 questions

Abingdon Health Plc free cash flow was −$3.5M for FY2025, down 107.5% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$5.3M.

ABDXF free cash flowABDXF FCFABDXF FCF 2025ABDXF free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Abingdon Health Plc · Abingdon Health Plc SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026